Role of Lavangadi churna in Grahani or Irritable bowel syndrome.

A randomized open labelled controlled clinical study to evaluate the efficacy of Lavangadi churna in Grahani with special reference to Irritable bowel syndrome. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099029

Enrollment

Registered

2025-12-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified Health Condition 2: K319- Disease of stomach and duodenum, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: B. INCLUSION CRITERIA Subjects with either gender of age group between 21-60 years. Subjects Diagnosed cases of Grahani. Established diagnosis of IBS (at least ROME-category 1V). Subjects who are willing to participate in the study with written consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Significant Improvement in symptoms of grahani assesed based on IBS qol score after 6 weeksTimepoint: Significant Improvement in symptoms of grahani assesed based on IBS qol score 6 weeks	—

Secondary

Measure	Time frame
Generation of the in depth analysis data on the different aspect of diseaseTimepoint: o,30,45th day	—

Countries

India

Contacts

Public ContactDr Sowmyashree U P

Sri Sri College of Ayurvedic science and research hospital, Bengaluru

upsprasad@gmail.com9743893056

Outcome results